Integra Holdings is a unique healthcare investment company, with an exclusive right to first examine the most promising innovations and IP emerging from the world renowned Hebrew University of Jerusalem.
With a diverse deal flow of Pharma Biotechnology, medical devices diagnostics and AI, Integra employs multidisciplinary team of experts who work alongside and take a hands-on approach to achieving commercial success. We provide know-how and support to our portfolio companies from inception to commercialization, while leveraging our extensive industry network cultivated over decades.
Integra Holdings was founded in 2012 by Yissum, the distinguished technology transfer company of the Hebrew University of Jerusalem. Shareholders include Temasek, Consensus Business Group (CBG), Invatech Holdings, The Israeli Teachers and Kindergarten funds, Halman-Aldubi Investment Group, the HU Provident fund, ZongHeng Group, and Heritage Investments.
Integra Holdings holds a diversified portfolio of nine companies in early to late stages – with established partnerships with leading investment funds such as Orbimed, IBF, Peregrine, aMoon, CF Foundation, Pontifax, Lundbeck fund, SROne, CBI and Biolight LifeSciences, as well as private investors.